News Focus
News Focus
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 10718

Friday, 07/26/2013 1:24:31 PM

Friday, July 26, 2013 1:24:31 PM

Post# of 20689
MNTA’s own PR on today’s Copaxone ruling:

http://finance.yahoo.com/news/momenta-pharmaceuticals-announces-potential-2014-171852956.html

"We are extremely pleased with today's ruling," said Craig Wheeler, President and Chief Executive Officer of Momenta. "Given the decision, we and Sandoz will continue to work with FDA to advance review of the ANDA for generic Copaxone in order for this product to be approved and available to patients as soon as possible."


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”